Jason D Robinson

Prof. Jason D Robinson

The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Psychology of Addictive Behaviors
Verified
Journal Article
Open access
JRJason D Robinson
Jason D Robinson
LLLiang Li
Liang Li
MCMinxing Chen
Minxing Chen
CLCaryn Lerman
Caryn Lerman
RTRachel F. Tyndale
Rachel F. Tyndale
PCPaul M. Cinciripini
Paul M. Cinciripini
Smokers attempting to quit often attribute smoking relapse to negative affect, craving, and other nicotine withdrawal symptoms. In addition, there is evidence that smoking relapse can increase these symptoms, particularly negative affect. To address this issue, we analyzed data from an 11-week smoking cessation clinical trial in which smokers (n = 1,246) were randomized to receive either nicotine replacement therapy (NRT), varenicline, or placebo, combined with behavioral counseling. Using cross-lagged analyses, we examined the temporal bidirectional relationships between self-reported measures of affect, craving, and composite withdrawal symptoms and biochemically verified smoking abstinence. The relative strength of these temporal relationships was examined by comparing the explained variances of the models. The results showed that higher negative affect, craving, and composite withdrawal symptoms increased the likelihood of subsequent smoking relapse, and that smoking relapse led to subsequent increases in these same symptoms. A comparison of the explained variances found symptom predicting subsequent relapse models to be stronger than those where relapse predicted subsequent symptoms. Although the explained variance findings generally support a negative reinforcement conceptualization of nicotine dependence, the bidirectional relationship between symptoms and smoking relapse suggests that struggling with quitting smoking leads to significant negative affect, craving, and other withdrawal symptoms that do not quickly resolve. These findings highlight the importance of addressing specific symptoms within the context of smoking cessation. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

1 January 2011 in Experimental and Clinical Psychopharmacology
Verified
Journal Article
Closed access
JRJason D Robinson
Jason D Robinson
CLCho Y. Lam
Cho Y. Lam
BCBrian L. Carter
Brian L. Carter
JMJennifer A. Minnix
Jennifer A. Minnix
YCYong Cui
Yong Cui
PCPaul M. Cinciripini
Paul M. Cinciripini
We used multimodal measurement to evaluate whether (a) nicotine dependence is associated with baseline and postquit negative affect and craving, (b) smoking relapse is associated with greater negative affect and craving than abstinence, and (c) craving is associated with negative affect. Treatment-seeking smokers were randomly assigned to either a brief behaviorally based smoking-cessation treatment condition or to a delayed treatment control condition. Participants in the treatment condition attended four assessment sessions, 4-5 days prequit (baseline), 1-2 days postquit, 3-5 days postquit, and 10-14 days postquit, while controls attended four sessions spaced over the same intervals. Retrospective questionnaires were collected at the beginning of each session, and corrugator EMG and in-session ratings were collected during viewing of affective and cigarette-related slides. The multimodal measures indicated that more dependent smokers experienced greater negative affect and craving at baseline and postquit, regardless of abstinence status. The self-report measures indicated that both relapsed and abstinent smokers reported greater negative affect and craving than control smokers. Craving was associated with negative affect across measurement modalities. These results highlight the benefits of using multimodal measures to study the impact of nicotine dependence and withdrawal on negative affect and craving.

21 April 2017 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
JRJason D Robinson
Jason D Robinson
PCPaul M. Cinciripini
Paul M. Cinciripini
MKMaher Karam‐Hage
Maher Karam‐Hage
HAHenri-Jean Aubin
Henri-Jean Aubin
LDLowell C. Dale
Lowell C. Dale
TGthe STRATUS Group
the STRATUS Group

26 December 2006 in The Pharmacogenomics Journal
Verified
Journal Article
Open access
PDF file
JRJason D Robinson
Jason D Robinson
CLC Y Lam
C Y Lam
JMJ A Minnix
J A Minnix
DWD W Wetter
D W Wetter
GTG E Tomlinson
G E Tomlinson
PCP M Cinciripini
P M Cinciripini
The dopamine receptor D2 (DRD2) gene has polymorphisms that have been linked to regulation of the dopamine system and to an increased prevalence of smoking. The present study examined the relationship of the DRD2 TaqI-A and -B polymorphisms with short-term clinical outcome (abstinence and withdrawal symptoms), collected from daily (14 pre-quit and 42 post-quit) diary data among smokers (n=116) treated with the nicotine patch plus either venlafaxine or placebo. The results showed that B1/B1 or B1/B2 smokers were slightly less likely to be abstinent on a given day than those homozygous for the TaqI-B2 allele. Significant DRD2 TaqI-B × time interactions were found for several of the withdrawal scales, indicating that those smokers with the B1/B1 or B1/B2 genotypes tended to report more symptoms over time compared to those with the B2/B2 genotype. No interactions or main effects were found for the DRD2 TaqI-A polymorphism. The findings demonstrate that smokers homozygous for the TaqI-B2 allele experience progressive improvement in self-reported withdrawal symptoms while smokers with the TaqI-B1 allele showing little change.

1 January 2015 in Experimental and Clinical Psychopharmacology
Verified
Journal Article
Closed access
JRJason D Robinson
Jason D Robinson
FVFrancesco Versace
Francesco Versace
JEJeffery M. Engelmann
Jeffery M. Engelmann
YCYong Cui
Yong Cui
ASAurelija Slapin
Aurelija Slapin
PCPaul M. Cinciripini
Paul M. Cinciripini
While smokers are known to find smoking-related stimuli motivationally salient, the extent to which former smokers do so is largely unknown. In this study, we collected event-related potential (ERP) data from former and never smokers and compared them to a sample of current smokers interested in quitting who completed the same ERP paradigm prior to smoking cessation treatment. All participants (n = 180) attended 1 laboratory session where we recorded dense-array ERPs in response to cigarette-related, pleasant, unpleasant, and neutral pictures and where we collected valence and arousal ratings of the pictures. We identified 3 spatial and temporal regions of interest, corresponding to the P1 (120-132 ms), early posterior negativity (EPN; 244-316 ms), and late positive potential (LPP; 384-800 ms) ERP components. We found that all participants produced larger P1 responses to cigarette-related pictures compared to the other picture categories. With the EPN component, we found that, similar to pleasant and unpleasant pictures, cigarette-related pictures attracted early attentional resources, regardless of smoking status. Both former and never smokers produced reduced LPP responses to cigarette-related and pleasant pictures compared to current smokers. Current smokers rated the cigarette-related pictures as being more pleasant and arousing than the former and never smokers. The LPP and picture-rating results suggest that former smokers, like never smokers, do not find cigarette-related stimuli to be as motivationally salient as current smokers.

1 March 2007 in Addictive Behaviors
Verified
Journal Article
Closed access
JRJason D Robinson
Jason D Robinson
PCPaul M. Cinciripini
Paul M. Cinciripini
STStephen T. Tiffany
Stephen T. Tiffany
BCBrian L. Carter
Brian L. Carter
CLCho Y. Lam
Cho Y. Lam
DWDavid W. Wetter
David W. Wetter